Jan 20, 2023· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2022-N-2673-0224
Please see the attached comments of the National Association of Chain Drug Stores (NACDS) in response to FDA's Request for Comments on the topic of Safety and Effectiveness of Certain Naloxone Hydrochloride Drug Products for Nonprescription Use.